Skip to main content
Clinical Trials/RBR-9bb2fpn
RBR-9bb2fpn
Recruiting
未知

Development and validation of a quality of life questionnaire related to symptoms of gastroesophageal reflux disease (QQV-GERD).

Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo0 sitesDecember 3, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Gastroesophageal reflux
Sponsor
Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2021
End Date
March 18, 2025
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo

Eligibility Criteria

Inclusion Criteria

  • Adults aged between 18 and 65 years of both genders with preserved comprehension capacity, literate, must sign the informed consent form before data collection and have typical and/or atypical symptoms of gastroesophageal reflux disease with results of upper digestive endoscopy, esophageal manometry and prolonged pH monitoring.

Exclusion Criteria

  • Adults with diagnosed psychiatric illness, neurological disease, neoplasms, patients with cognitive impairment, illiterate patients and patients with severe visual impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials